Idiopathic Cd4 Lymphocytopenia
📧 Sign up to get email alerts when something new happens for Idiopathic Cd4 Lymphocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
This clinical trial registry entry describes a study on the etiology, pathogenesis, and natural history of idiopathic CD4+ lymphocytopenia. …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models [Phase 2]
Phase 2 clinical trial assessing hematopoietic stem cell mobilization in idiopathic CD4+ lymphocytopenia patients and healthy controls to st…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Idiopathic CD4 Lymphocytopenia
This document provides an update on a completed clinical trial investigating idiopathic CD4 lymphocytopenia.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia [Phase 1, Phase 2]
A Phase 1/2, single-arm, dose-escalation trial evaluating long-acting recombinant human IL-7 (NT-I7/efineptakin alfa) in idiopathic CD4+ lym…